![Hypervision Surgical Accepted for FDA’s Safer Technologies Program](https://hypervisionsurgical.com/images/blog/2024-04_FDA-STeP_thumbnail.webp)
Hypervision Surgical Accepted for FDA’s Safer Technologies Program
Hypervision Surgical announced that its first product has been accepted into the U.S. Food and Drug Administration’s (FDA’s) Safer Technologies Program.
Read moreHypervision Surgical announced that its first product has been accepted into the U.S. Food and Drug Administration’s (FDA’s) Safer Technologies Program.
Read moreHypervision Surgical has expanded its management team with the appointment of Josh Gibson as Head of Technology.
Read moreWe are excited to welcome Siloé Bournez as the newest member of our R&D team for an internship at Hypervision Surgical, reflecting our ongoing expansion efforts.
Read moreWe are thrilled to announce that Hypervision Surgical has relocated its headquarters to the London Institute for Healthcare Engineering (LIHE) at King’s College London, situated within the vibrant St Thomas’ MedTech Hub, marking a significant milestone in our journey of expansion and innovation.
Read moreHypervision Surgical has further grown its team, with Edward James joining as Software Engineer. Edward is a Veterinary Surgeon who retrained in Biomedical Engineering in 2014, and has been involved in Biomedical Optics Research since 2016.
Read moreHypervision Surgical, a London-based health-tech venture working to make surgery safer and more accurate by giving surgeons a ‘superhuman’ level of vision, is delighted to announce the appointment of Martin Frost CBE as the company’s Chairman.
Read more